Insider filing · DNTH
Ryan Savitz
EVP, CFO & CBO
profile →
Dianthus Therapeutics, Inc.
DNTH · Healthcare · 18 filings in 24 months
ticker →
Ryan Savitz sold $700K of Dianthus Therapeutics (DNTH)
Executed Sep 9 2025, disclosed Sep 11 2025, 2 days later.
Value, as filed
$700K
20,000 sh × $35.00
Executed
Sep 9 2025
the trade date, as filed
Disclosed
Sep 11 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RSRyan Savitz (EVP, CFO & CBO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $9.4M of DNTH (113,567 sh across 7 lots, as filed), executed Mar 31.
The name
DNTHHealthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ryan Savitz in DNTH
DNTHSALE
Dianthus Therapeutics, Inc.
$3.2M31,249 sh across 3 lots
Exec Jul 9
Filed Jul 13 · 5:00 PM ET DNTHSALE Dianthus Therapeutics, Inc. $739K
8,224 sh × $89.84
Exec Apr 9
Filed Apr 10 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. $9.4M
113,567 sh across 7 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. $904K
20,000 sh × $45.18
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET